11 results on '"Toh, Yasushi"'
Search Results
2. Simple systemic index associated with oxaliplatin‐induced liver damage can be a novel biomarker to predict prognosis after resection of colorectal liver metastasis.
- Author
-
Shimagaki, Tomonari, Sugimachi, Keishi, Mano, Yohei, Onishi, Emi, Iguchi, Tomohiro, Uehara, Hideo, Sugiyama, Masahiko, Yamamoto, Manabu, Morita, Masaru, and Toh, Yasushi
- Subjects
COLORECTAL liver metastasis ,LIVER ,LIVER cancer ,INDOCYANINE green ,PROGNOSIS ,POLYPOIDAL choroidal vasculopathy ,PORTAL vein diseases - Abstract
Aim: Oxaliplatin, an anticancer drug for advanced colorectal cancer, causes liver sinusoidal damage, sometimes with portal hypertension. We conducted a retrospective comparative study of the relationship of liver sinusoidal disorders and liver function with the prognosis in patients who underwent hepatectomy for colorectal liver metastasis (CRLM). Methods: In total, 158 patients who underwent hepatectomy for CRLM were included in the study, and the effect of chemotherapy‐associated liver damage on the prognosis was examined. Results: Preoperative oxaliplatin was used in 75 of 158 patients; of these 75 patients, 26 had intraoperative blue liver (BL). In a comparison of the BL group (n = 26) and non‐BL group (n = 132), patients in the BL group had a significantly lower serum albumin concentration and a significantly higher indocyanine green test result, aspartate aminotransferase‐to‐platelet ratio index (APRI), and FIB‐4 score. Operative morbidities were not significantly different between the two groups. The overall survival rate after hepatectomy was significantly worse in the BL group than in the non‐BL group. In the univariate analysis, the serum albumin concentration, indocyanine green test, a high tumor burden score (TBS), and the APRI were statistically significant poor prognostic factors. In the multivariate analysis, the APRI and a high TBS were independent poor prognostic factors. Conclusion: The APRI and TBS in patients with CRLM are prognostic predictors after hepatectomy for metastatic liver cancer. This study indicated that liver damage in patients treated with preoperative oxaliplatin has an effect on the prognosis. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
3. The treatment outcomes of synchronous and metachronous esophageal squamous cell carcinoma and head and neck squamous cell carcinoma
- Author
-
Saeki, Hiroshi, Toh, Yasushi, Morita, Masaru, Sugiyama, Masahiko, Morita, Kazutoyo, Sakamoto, Yasuo, Soejima, Yuji, Minami, Kazuhito, Sakaguchi, Yoshihisa, Higaki, Yuichiro, Uehara, Satoru, Okamura, Takeshi, and Maehara, Yoshihiko
- Published
- 2012
- Full Text
- View/download PDF
4. The clinical characteristics of patients with synchronous squamous cell carcinoma of the esopohagus and hepatocellular carcinoma
- Author
-
Morita, Masaru, Kuwano, Hiroyuki, Toh, Yasushi, Matsuda, Hiroyuki, Matsumata, Takashi, and Sugimachi, Keizo
- Published
- 1994
- Full Text
- View/download PDF
5. Benefits of laparoscopic surgery compared to open standard surgery for gastric carcinoma in elderly patients: propensity score-matching analysis.
- Author
-
Yamamoto, Manabu, Shimokawa, Mototsugu, Kawano, Hiroyuki, Ohta, Mitsuhiko, Yoshida, Daisuke, Minami, Kazuhito, Ikebe, Masahiko, Morita, Masaru, and Toh, Yasushi
- Subjects
LAPAROSCOPIC surgery ,STOMACH cancer treatment ,OLDER patients ,GASTRECTOMY ,MULTIVARIATE analysis ,COMPARATIVE studies ,SURGICAL excision ,LAPAROSCOPY ,LYMPH node surgery ,RESEARCH methodology ,MEDICAL cooperation ,METASTASIS ,PROBABILITY theory ,PROGNOSIS ,RESEARCH ,STOMACH tumors ,SURGICAL complications ,SURVIVAL ,EVALUATION research ,DISEASE incidence - Abstract
Background: Laparoscopic surgery is frequently performed, and laparoscopic gastrectomy (LG) is also widely performed for gastric cancer. Elderly population with gastric cancer has increased in East Asia, including in Japan.Methods: We examined 1131 patients with gastric cancer who underwent laparoscopic and open standard surgeries (OG). A total of 921 patients of age < 75 years (non-E group) and 210 patients of age ≥ 75 years (E group) underwent surgery for gastric cancer. The mortality, morbidity, and prognosis of LG and OG were compared by propensity score-matched analysis.Results: Mortality and morbidity in the E group were significantly higher than those in the non-E group (p < 0.05). Propensity score-matching revealed that the incidence of postoperative complications of grade ≥ 2 in the OG subgroup was significantly higher than that in the LG subgroup in the E group (p < 0.05). The overall survival rate of the LG subgroup was significantly higher than that of the OG subgroup in both the non-E and E groups (p < 0.05). The depth of tumor invasion, lymph node metastasis, and the number of dissected lymph nodes were dependent factors for survival in the non-E group, whereas the depth of tumor invasion was the only dependent factor for survival in the E group in the multivariate analysis.Conclusion: The survival rate of patients who underwent LG showed significantly good prognosis in both the non-E and E groups, although the E group patients who underwent OG subgroup showed higher severe complication incidences than those who underwent LG subgroup. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
6. Esophageal stenosis and the Glasgow Prognostic Score as independent factors of poor prognosis for patients with locally advanced unresectable esophageal cancer treated with chemoradiotherapy (exploratory analysis of JCOG0303).
- Author
-
Okuno, Tatsuya, Wakabayashi, Masashi, Kato, Ken, Shinoda, Masayuki, Katayama, Hiroshi, Igaki, Hiroyasu, Tsubosa, Yasuhiro, Kojima, Takashi, Okabe, Hiroshi, Kimura, Yusuke, Kawano, Tatsuyuki, Kosugi, Shinichi, Toh, Yasushi, Kato, Hoichi, Nakamura, Kenichi, Fukuda, Haruhiko, Ishikura, Satoshi, Ando, Nobutoshi, and Kitagawa, Yuko
- Subjects
ESOPHAGEAL stenosis ,PROGNOSIS ,PROGRESSION-free survival ,ESOPHAGEAL cancer ,CHEMORADIOTHERAPY ,SQUAMOUS cell carcinoma - Abstract
Background: The aim of this study was to investigate the possible prognostic factors and predictive accuracy of the Glasgow Prognostic Score (GPS) for patients with unresectable locally advanced esophageal squamous cell carcinoma (LAESCC) treated with chemoradiotherapy. Methods: One hundred forty-two patients were enrolled in JCOG0303 and assigned to the standard cisplatin and 5-fluorouracil (PF)-radiotherapy (RT) group or the low-dose PF-RT group. One hundred thirty-one patients with sufficient data were included in this analysis. A Cox regression model was used to analyze the prognostic factors of patients with unresectable LAESCC treated with PF-RT. The GPS was classified based on the baseline C-reactive protein (CRP) and serum albumin levels. Patients with CRP ≤1.0 mg/dL and albumin ≥3.5 g/dL were classified as GPS0. If only CRP was increased or only albumin was decreased, the patients were classified as GPS1, and the patients with CRP >1.0 mg/dL and albumin <3.5 g/dL were classified as GPS2. Results: The patients' backgrounds were as follows: median age (range), 62 (37-75); male/female, 119/12; ECOG PS 0/1/2, 64/65/2; and clinical stage (UICC 5th) IIB/III/IVA/IVB, 3/75/22/31. Multivariable analyses indicated only esophageal stenosis as a common factor for poor prognosis. In addition, overall survival tended to decrease according to the GPS subgroups (median survival time (months): GPS0/GPS1/GPS2 16.1/14.9/8.7). Conclusions: Esophageal stenosis was identified as a candidate stratification factor for randomized trials of unresectable LAESCC patients. Furthermore, GPS represents a prognostic factor for LAESCC patients treated with chemoradiotherapy. Clinical Trial Information: UMIN000000861. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
7. Suture granuloma with false-positive finding on PET/ CT after gastrectomy for gastric cancer.
- Author
-
Tsujita, Eiji, Ikeda, Yasuharu, Kinjo, Nao, Yamashita, Yo‐ichi, Kumagai, Reiko, Taguchi, Ken‐ichi, Yamaguchi, Shohei, Minami, Kazuhito, Yamamoto, Manabu, Morita, Masaru, Toh, Yasushi, and Okamura, Takeshi
- Subjects
LYMPHADENECTOMY ,GRANULOMA ,STOMACH cancer ,STOMACH cancer treatment ,FLUORODEOXYGLUCOSE F18 ,PROGNOSIS - Abstract
This study is a case report on a 49-year-old woman who had a gastrectomy and lymphadenectomy for pStage IIIa gastric cancer. Shortly after a 12-month course of adjuvant chemotherapy, CT showed a nodule adjacent to the gallbladder. High
18 F-fluorodeoxyglucose accumulation was detected, with a standardized uptake value of 10. Therefore, laparoscopic excision was performed for diagnosis and treatment. The histopathological finding was suture granuloma. Suture granulomas with high standardized uptake values on PET scans are uncommon and often cause surgeons to provide an inaccurate diagnosis. Our study suggests that suture granuloma should be included in the differential diagnosis of a new or recurrent mass detected in patients with a history of prior surgery; however, surgeons must bear in mind that false-positive fluorodeoxyglucose- PET results can be observed in suture granuloma. [ABSTRACT FROM AUTHOR]- Published
- 2015
- Full Text
- View/download PDF
8. The Significance of Fibroblast Growth Factor Receptor 2 Expression in Differentiation of Hepatocellular Carcinoma.
- Author
-
Harimoto, Norifumi, Taguchi, Kenichi, Shirabe, Ken, Adachi, Eisuke, Sakaguchi, Yoshihisa, Toh, Yasushi, Okamura, Takeshi, Kayashima, Hiroto, Taketomi, Akinobu, and Maehara, Yoshihiko
- Subjects
LIVER cancer ,CELL differentiation ,FIBROBLAST growth factors ,GENE expression ,CANCER invasiveness - Abstract
Fibroblast growth factor receptors (FGFRs) have been reported to be involved in the progression of many cancers. The aim of this study is to clarify the significance of FGFR2 expression in the differentiation of hepatocellular carcinoma (HCC). One nodule-in-nodule HCC sample was obtained from a patient to analyze the different expression in well- to moderately differentiated HCC and poorly differentiated HCC using microarray technique. The expression of FGFR2 in 46 patients with surgically resected HCC was immunohistochemically examined and analyzed in relation to their clinicopathological factors. Fgfr2 was 4.7 times up-regulated in poorly differentiated HCC from a nodule-in-nodule sample. The high expression group was 16 cases and the low expression group was 30 cases. The high FGFR2 expression correlated significantly with a poor histological differentiation, a higher incidence of portal vein and a high level of alpha-fetoprotein. The overall survival rates and the disease-free survival rates in high expression were significantly worse than those in low. In conclusion, a high FGFR2 expression plays an important role in poor differentiation, portal vein invasion, high alpha-fetoprotein production, and poor prognosis. These data suggest that FGFR2 may be a potentially useful biological marker of tumor invasiveness in HCC as well as a novel molecular target for HCC. Copyright © 2010 S. Karger AG, Basel [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
9. Peritoneal lavage CEA/CA125 is a prognostic factor for gastric cancer patients.
- Author
-
Yamamoto, Manabu, Baba, Hideo, Toh, Yasushi, Okamura, Takeshi, and Maehara, Yoshihiko
- Subjects
PERITONEAL dialysis ,CARCINOEMBRYONIC antigen ,CANCER invasiveness ,PROGNOSIS ,TUMOR markers ,CHEMILUMINESCENCE immunoassay - Abstract
We recently found an elevation in the pre-operative peritoneal lavage carcinoembryonic antigen (CEA) level to be associated with an earlier detection of recurrent peritoneal dissemination and a poor prognosis. Two hundred and twenty-nine patients with gastric cancer were intraoperatively measured for tumor markers, CEA and CA125 based on peritoneal lavage using a chemiluminescent enzyme immunoassay. The patients were divided into four groups. (A) The peritoneal lavage CEA (−) CA125 (−) group (CEA < 0.4 ng/ml, CA125 < 200 ng/ml, n = 129); (B) the peritoneal lavage CEA (−) CA125 (+) group (CEA < 0.4 ng/ml, CA125 ≧ 200 ng/ml, n = 50); (C) the peritoneal lavage CEA (+) CA125 (−) group (CEA ≧ 0.4 ng/ml, CA125 < 200 ng/ml, n = 18); and (D) the peritoneal lavage CEA (+) CA125 (+) group (CEA ≧ 0.4 ng/ml, CA125 ≧ 200 ng/ml, n = 32). The 5-year survival of the patients in groups C and D was 40 and 26%, respectively, which was lower than that of the patients in any other group (group A, B; p < 0.0001). Recurrent sites were both peritoneal dissemination and lymph node/liver in group C, while those were only peritoneal dissemination in group D. This combined analysis of these markers is therefore considered to be helpful method to accurately estimate the recurrent sites and prognosis for advanced gastric cancer patients. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
10. Prognostic Significance of Tumor Markers in Peritoneal Lavage in Advanced Gastric Cancer.
- Author
-
Yamamoto, Manabu, Baba, Hideo, Kakeji, Yoshihiro, Endo, Kazuya, Ikeda, Yasuharu, Toh, Yasushi, Kohnoe, Shunji, Okamura, Takeshi, and Maehara, Yoshihiko
- Subjects
PROGNOSIS ,STOMACH cancer ,DIAGNOSTIC use of tumor markers ,BIOMARKERS ,TUMORS - Abstract
Objective: Predicting peritoneal dissemination of cancer is very difficult whatever method of examination is used. Recently, a cytological examination of peritoneal lavage has been shown to be a feasible measure to predict an early state of peritoneal seeding. The predictive value of the levels of tumor markers in peritoneal lavage for peritoneal metastasis from gastric carcinoma was thus studied. Methods: In 229 patients gastric cancer tumor markers, CEA, CA 125, and CA 19-9, in peritoneal lavage were intraoperatively evaluated using a chemiluminescent enzyme immunoassay. Results: CEA in peritoneal lavage at a cutoff level of 0.5 ng/ml showed overall a higher sensitivity of 75.8% at a specificity of 90.8% for a diagnosis of peritoneal dissemination including cytologically positive peritoneal lavage [CY(+)] than CA 125 or CA 19-9 in peritoneal lavage. The CEA level in peritoneal lavage as well as both serosal invasion and the CA 125 level in peritoneal lavage were significant factors for the prediction of peritoneal dissemination including CY(+) with a relative risk of 6.6, 14.1 and 9.4. In patients undergoing curative operations, the recurrence rate for peritoneal dissemination and liver metastasis in cases with CEA levels in peritoneal lavage of ≥0.5 ng/ml was significantly higher than that in cases with CEA levels of <0.5 ng/ml (p < 0.0001, p < 0.002). Conclusions: These finding suggest that the CEA level in peritoneal lavage is thus considered to be a predictor of peritoneal dissemination including CY(+). Copyright © 2004 S. Karger AG, Basel [ABSTRACT FROM AUTHOR]
- Published
- 2004
- Full Text
- View/download PDF
11. Postoperative Neutrophil-to-Lymphocyte Ratio as a Predictor of Long-Term Prognosis after Pancreatectomy for Pancreatic Carcinoma: A Retrospective Analysis.
- Author
-
Tsujita, Eiji, Ikeda, Yasuharu, Kinjo, Nao, Yamashita, Yo-Ichi, Hisano, Terumasa, Furukawa, Masayuki, Taguchi, Ken-Ichi, Morita, Masaru, Toh, Yasushi, and Okamura, Takeshi
- Subjects
- *
LYMPHOCYTE metabolism , *ADENOCARCINOMA , *NEUTROPHILS , *PANCREATIC tumors , *PANCREATECTOMY , *POSTOPERATIVE period , *PROGNOSIS , *SURVIVAL analysis (Biometry) , *TREATMENT effectiveness , *PREDICTIVE tests , *RETROSPECTIVE studies , *LEUKOCYTE count - Abstract
To clarify the prognostic value of the postoperative blood neutrophil-to-lymphocyte ratio (NLR) in patients undergoing pancreatectomy for pancreatic carcinoma (PAC). A high preoperative NLR has been reported to be a predictor of poor survival in patients with various cancers including PAC. However, it has not been extensively examined in postoperative NLR after pancreatectomy for PAC. This retrospective study enrolled 86 patients who underwent pancreatectomy without preoperative therapy for PAC from 2005 to 2013. Clinicopathological parameters, including postoperative NLR, were evaluated to identify predictors of the overall and recurrence-free survival of patients after pancreatectomy. Univariate and multivariate analyses were performed, using the Cox proportional hazards model. Univariate and multivariate analyses showed that postoperative NLR at one month was an independent prognostic factor in the overall and recurrence-free survival of patients. The 3-year survival rate after pancreatectomy was as follows: 33.9 per cent in patients with a postoperative NLR of less than 3.0 at one month; and 7.3 per cent in those with a postoperative NLR of 3.0 or more at one month (P < 0.001). The overall survival rate after pancreatectomy in the NLR at one month ≥3.0 group was significantly lower than in the NLR at one month <3.0 group: one year, 42.6 versus 81.9 per cent; three year, 7.3 versus 33.9 per cent (P < 0.001). The results of the study suggest that the postoperative NLR at one month is an independent predictor of survival after pancreatectomy in patients with PAC. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.